These trials completed more than 12 months ago and should have reported results.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2006-003387-55||" A Prospective, Randomized, Double Blind, Multicenter Study to Compare the Efficacy, Safety and Tolerability of CDB-2914 with Levonorgestrel as Emergency Contraception Within 120 Hours Unprotected In...||2009-03-30||due-trials|
|Reported results Terminated||2006-004679-36||Prospective, open-label, multicenter, international study of mifepristone for symptomatic treatment of Cushing s syndrome caused by ectopic Adrenal Corticotrophin Hormone ACTH secretion||2012-04-04||due-trials|
|Reported results||2011-005573-23||A prospective, randomized, double-blind parallel-arm, placebo-controlled study to assess the effects on ovarian activity of a combined oral contraceptive pill when preceded by the intake of ellaOne® (...||2012-08-31||due-trials|
|Listed as ongoing, but also has a completion date||2014-000162-22||Prospective, single arm, open-label, multicenter, international study to assess the effects of metyrapone in patients with endogenous Cushing’s syndrome during a 12-week treatment period followed by a...||2020-04-29||bad-data|
|Reported results||2017-002283-41||A prospective, randomized, parallel-group study to assess the effects on ovarian activity of ellaOne (ulipristal acetate 30 mg single dose) taken after three consecutive days of missed combined oral c...||2018-05-28||due-trials|